Prothena Corporation PLC (NASDAQ:PRTA)

Data as of Jan 30
 -0.12 / -0.53%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Prothena Corp. Plc is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion. It focuses on therapeutic monoclonal antibodies directed specifically to disease causing proteins. The company's antibody-based product candidates target a number of potential indications including AL and AA forms of amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002) and novel cell adhesion targets involved in inflammatory diseases and cancers (PRX003). Prothena was founded on September 26, 2012 and is headquartered in Dublin, Ireland.

Contact Information

Prothena Corp. Plc
Alexandra House
Dublin Dublin 4
P:(531) 902-3519
Investor Relations:
(650) 837-8535



Mutual fund holders68.24%
Other institutional27.62%
Individual stakeholders11.71%

Top Executives

Dale B. SchenkPresident, Chief Executive Officer & Director
Tran B. NguyenChief Financial Officer & Head-Investor Relations
Gene G. KinneyChief Scientific Officer
Martin KollerChief Medical Officer
Karin L. WalkerChief Accounting Officer & Controller

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.